MYCN and neuroblastoma: However, the absence of caspase-2 is not sufficient to promote tumorigenesis in the MYCN-driven neuroblastoma model [11] or following 3-methylcholanthrene (3-MC)-induced fibrosarcoma and irradiation-driven lymphoma [12].